Your browser doesn't support javascript.
loading
Repeatability and sensitivity to change of non-invasive end points in PAH: the RESPIRE study.
Swift, Andrew J; Wilson, Frederick; Cogliano, Marcella; Kendall, Lindsay; Alandejani, Faisal; Alabed, Samer; Hughes, Paul; Shahin, Yousef; Saunders, Laura; Oram, Charlotte; Capener, David; Rothman, Alex; Garg, Pankaj; Johns, Christopher; Austin, Matthew; Macdonald, Alistair; Pickworth, Jo; Hickey, Peter; Condliffe, Robin; Cahn, Anthony; Lawrie, Allan; Wild, Jim M; Kiely, David G.
Afiliación
  • Swift AJ; Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, UK a.j.swift@sheffield.ac.uk.
  • Wilson F; Research and Development, GlaxoSmithKline, Stevenage, Hertfordshire, UK.
  • Cogliano M; Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, UK.
  • Kendall L; Research and Development, GlaxoSmithKline, Stevenage, Hertfordshire, UK.
  • Alandejani F; Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, UK.
  • Alabed S; Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, UK.
  • Hughes P; Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, UK.
  • Shahin Y; Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, UK.
  • Saunders L; Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, UK.
  • Oram C; Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, UK.
  • Capener D; Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, UK.
  • Rothman A; Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, UK.
  • Garg P; Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, UK.
  • Johns C; Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, UK.
  • Austin M; Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, UK.
  • Macdonald A; Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, UK.
  • Pickworth J; Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, UK.
  • Hickey P; Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, UK.
  • Condliffe R; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK.
  • Cahn A; Research and Development, GlaxoSmithKline, Stevenage, Hertfordshire, UK.
  • Lawrie A; Department of Respiratory Medicine, Bedford Hospital, Bedford, UK.
  • Wild JM; Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, UK.
  • Kiely DG; Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, UK.
Thorax ; 76(10): 1032-1035, 2021 10.
Article en En | MEDLINE | ID: mdl-33632769
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Hipertensión Arterial Pulmonar / Hipertensión Pulmonar Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Thorax Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Hipertensión Arterial Pulmonar / Hipertensión Pulmonar Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Thorax Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido